By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Capricor Therapeutics, Inc. 

8700 Beverly Boulevard
Davis Building - Room D-1063
Los Angeles  California  90048  U.S.A.
Phone: n/a Fax: n/a



Company News
Capricor Therapeutics, Inc. And CureDuchenne To Host Webinar On January 21, 2015 At 3:00 P.M. ET 1/21/2015 7:40:59 AM
Capricor Therapeutics, Inc. Initiates The DYNAMIC Clinical Trial For The Treatment Of Advanced Heart Failure 1/13/2015 6:55:05 AM
Cure Duchenne Ventures LLC To Provide $1 Million To Capricor Therapeutics, Inc. To Advance Promising Research To Treat Heart Disease Associated With Duchenne Muscular Dystrophy 1/12/2015 10:38:03 AM
Capricor Therapeutics, Inc. Announces $10 Million Private Placement Of Common Stock 1/12/2015 7:54:20 AM
Capricor Therapeutics, Inc. Announces Linda Marban, Ph.D. Will Present A Company Overview And Serve As An Expert Panelist At Piper Jaffray's 26th Annual Healthcare Conference 12/5/2014 10:41:21 AM
Capricor Therapeutics, Inc. Announces Favorable ALLSTAR Phase I Safety Results 11/18/2014 11:51:10 AM
Capricor Therapeutics, Inc. Reports Third Quarter 2014 Financial & Business Highlights 11/12/2014 8:05:29 AM
Capricor Therapeutics, Inc. To Hold Duchenne Muscular Dystrophy Data Presentation Call On November 18, 2014 At 9:30 A.M. ET 11/7/2014 12:13:58 PM
Capricor Therapeutics, Inc. To Hold Third Quarter 2014 Business Update Conference Call On November 12, 2014 At 4:30 P.M. ET 10/31/2014 7:41:21 AM
Capricor Therapeutics, Inc. Announces Acquisition Of Intellectual Property Rights To Family Of Natriuretic Peptides From Medtronic, Inc. (MDT) 10/14/2014 7:13:45 AM